Phase III trial of topical interferon alpha-2b in patients with cervical dysplasia.

Trial Profile

Phase III trial of topical interferon alpha-2b in patients with cervical dysplasia.

Planning
Phase of Trial: Phase III

Latest Information Update: 18 May 2012

At a glance

  • Drugs Interferon alpha-2b (Primary)
  • Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 18 May 2012 The Federal Institute for Drugs and Medical Devices in Germany approves CTA application for this trial, according to a Helix BioPharma media release.
    • 16 Mar 2012 The Medicines and Healthcare Regulatory Authority in the United Kingdom grants conditional approval for the phase III trial application, according to a Helix BioPharma media release.
    • 22 Dec 2011 Helix has filed clinical trial applications with regulatory authorities in Germany (BfArM) and the UK (MHRA) seeking approval to conduct this trial, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top